News & Information
At Memorial Sloan Kettering, our leading edge research is constantly advancing what we know about cancer and new discoveries are improving care for patients here, and all over the world. In News and Information, you will find information about our groundbreaking work and the dedicated professionals who make it all happen.
For Journalists
Connect with us to reach MSK experts for media inquiries and for story ideas.
MSK received top rankings in gynecology, urology, and several subspecialties
For more than 137 years, MSK has made historic contributions driving discovery and improving patient care. Take a look back at the progress we've made since the signing of the National Cancer Act in 1971.
In the News
Rectal cancer patients saw their tumors disappear in a clinical trial involving immunotherapy at Memorial Sloan Kettering Cancer Center—without surgery, radiation, or chemotherapy.
At the annual ASCO meeting, MSK medical oncologist Shanu Modi is presenting results from a clinical trial that found more people can benefit from a targeted therapy for breast cancer than previously thought.
Learn how proton therapy can be an effective new treatment for leptomeningeal metastasis.
Stay Connected with MSK
News Releases
Breakthrough findings were presented at the 2022 ASCO Annual Meeting and published in The New England Journal of Medicine today by researchers at Memorial Sloan Kettering Cancer Center (MSK) confirming a clinical complete response in all 14 patients who received the immunotherapy treatment dostarlimab as a first-line treatment for mismatch repair-deficient (MMRd) locally advanced rectal cancer. This new approach of “immunoablative” therapy uses immunotherapy to replace surgery, chemotherapy and radiation to remove cancer.
New data from researchers at MSK featured in the 2022 ASCO Annual Meeting press program and simultaneously published in The New England Journal of Medicine highlights a novel antibody-drug conjugate that doubled progression-free survival in HER2-low metastatic breast cancer.
Physicians and scientists from MSK will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2022 ASCO Annual Meeting, June 3–7 in Chicago.
Media Coverage
A small clinical trial conducted by Memorial Sloan Kettering Cancer Center found that every single rectal cancer patient who received an experimental immunotherapy treatment had their cancer go into remission. MSK’s Luis Diaz Jr. and Andrea Cercek are featured.
Wednesday, June 8, 2022
On Feb 2, 2022, President Joe Biden announced plans to relaunch the Cancer Moonshot initiative as part of his ongoing determination to “end cancer as we know it” in the USA. Around 100 cancer researchers, patients, and advocates gathered at the White House to hear the president’s address, in which he renewed his pledge to improve the experience of those living with cancer. The news was accompanied by a call to action by the President and First Lady Jill Biden on cancer screenings, which have fallen behind as a result of the COVID-19 pandemic, with the hope that the growing backlog can be urgently addressed. MSK’s Lisa DeAngelis is quoted.
Wednesday, June 8, 2022
Stephanie Schmidt, a 30-year-old neonatal intensive care unit nurse in New York, was 8-weeks pregnant when she walked through the doors of her OBGYN for a routine visit to establish prenatal care. What started as a routine visit for Schmidt ended with her doctor finding a breast lump on her physical exam. A subsequent biopsy of the mass revealed the news she least expected from a prenatal visit: She had breast cancer.. MSK’s Devika Gajria is quoted.
Wednesday, June 8, 2022
News from the Lab
Chris Bourne is the first recipient of the MERIT Sawyers Fellowship.
Data from 25,000 patients is helping scientists answer this and many other important questions.
A new type of engineered immune cell could be a potent treatment for cancers that have escaped other immunotherapies.
MSK News
Symantha Wilson was crushed when chemotherapy quit fighting her lymphoma — and thrilled when immuno¬therapy beat back the cancer. But why doesn’t immunotherapy help more people? MSK researchers are finding answers.
This new era of cancer research investigates how the disease in certain locations interacts with all the body’s systems. Focusing on cancer’s ecosystem promises to reveal lifesaving insights, especially into metastasis.
To help Bridget Anderson overcome leukemia, MSK doctors called upon her own microbiome, the vast ecosystem of microorganisms that live within us, especially the gut. They’re both friend and foe in fighting cancer.
2020 Annual Report: Meeting the Moment
MSK researchers like physician-scientist Karuna Ganesh are using an innovative technology called organoids to unlock the mysteries of cancer metastasis.
In her new role as Chief Health Equity Officer, gynecologic cancer surgeon Carol Brown is leading a new commitment to reducing cancer disparities. Dr. Brown spoke with NBC’s Today show anchor Al Roker about raising awareness about these disparities.
Memorial Sloan Kettering staff, patients, and donors stepped up in extraordinary ways during the COVID-19 pandemic. Meet just some of these heroes.
